![Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ](https://www.bmj.com/content/bmj/339/bmj.b2998/F2.large.jpg)
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ
![Novel tumor biochemical markers for early detection of ovarian cancer. | Download Scientific Diagram Novel tumor biochemical markers for early detection of ovarian cancer. | Download Scientific Diagram](https://www.researchgate.net/publication/335918323/figure/tbl1/AS:804825012903945@1568896644360/Novel-tumor-biochemical-markers-for-early-detection-of-ovarian-cancer.png)
Novel tumor biochemical markers for early detection of ovarian cancer. | Download Scientific Diagram
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.fig13.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7968dca1873e681e0be5dd4a14690d730da0e0b2/4-Table1-1.png)
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar
![Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.347130144/asset/images/medium/rg.347130144.tbl2.gif)